AVNS

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Avanos Medical Inc

Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
CEO
Joseph Woody
Employees
5300
Headquarters

5405 Windward Parkway
Alpharetta, Georgia 30004
Phone: 16784259273
avanos.com

News

Avanos Medical Appoints New SVP for Supply Chain Optimization
May 13, 2024 11:32am

Avanos Medical (AVNS) has issued an announcement. Avanos Medical, Inc. has announced the appointment of Sigfrido (Sig) Delgado as the new Senior Vi…


Source:TipRanks
AVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024
May 02, 2024 15:56pm

Avanos Medical (NYSE: AVNS ) just reported results for the first quarter of 2024. Avanos Medical reported earnings per share of 19 cents. This was below the analyst estimate for EPS of 21 cents. The company reported revenue of $166.10 million. This was 1.96% better than the analyst estimate for revenue of $162.90 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I.


Source:InvestorPlace